GlassScriptPhysician profile
James A Leithead
NPI 1437473469
$8,114.32
in general payments reported to CMS, 2019-2025
32 companies · $631 in 2025
The $631 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $791 · 2020: $167 · 2021: $318 · 2022: $401 · 2023: $5,152 · 2024: $655 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,200 · Food and Beverage: $2,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,200.00 |
| Food and Beverage | $2,237.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flexdex INC. | $4,200.00 | 2023 | |
| Baxter Healthcare | $714.64 | 2021-2024 | Tisseel, Floseal |
| Covidien LP | $506.49 | 2019 | |
| Novo Nordisk INC | $468.20 | 2019-2025 | Wegovy, Saxenda |
| Ethicon US, LLC | $273.98 | 2022-2025 | Echelon Flex, Harmonic |
| Takeda Pharmaceuticals U.S.A., INC. | $219.04 | 2020-2025 | Gattex |
| Redhill Biopharma INC. | $151.60 | 2020-2023 | Aemcolo, Talicia, Movantik |
| Intra-Sana Laboratories | $150.11 | 2024-2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Lilly USA, LLC | $149.52 | 2023-2025 | Zepbound, Mounjaro |
| Apollo Endosurgery US INC | $136.82 | 2023 | Overstitch Endoscopic Suturing System |
| Intuitive Surgical, INC. | $127.93 | 2019-2023 | Da Vinci Surgical System |
| Asensus Surgical, INC. | $121.31 | 2019 | |
| Kvk-Tech, INC. | $120.86 | 2019-2025 | |
| Echosens North America, INC. | $116.00 | 2023 | Fibroscan |
| Davol INC. | $106.14 | 2020-2025 | Phasix Mesh |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $90.56 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Medtronic, INC. | $78.76 | 2023-2024 | Signia |
| Endo Pharmaceuticals INC. | $53.00 | 2020 | |
| Currax Pharmaceuticals LLC | $48.62 | 2020-2022 | |
| Smith+Nephew, INC. | $35.93 | 2025 | Stravix Pl |
| Steris Corporation | $32.27 | 2019 | |
| Shire North American Group INC | $31.62 | 2019 | |
| Allergan, INC. | $24.95 | 2021 | |
| Convatec INC. | $21.97 | 2022 | |
| Argon Medical Devices, INC. | $20.65 | 2023 | Cleaner |
| Vertex Pharmaceuticals Incorporated | $20.42 | 2025 | |
| Dilon Technologies, INC. | $19.62 | 2024 | Hemoblast Bellows |
| Phathom Pharmaceuticals, INC. | $18.86 | 2024 | Voquezna |
| Tela Bio, INC. | $17.71 | 2024 | Ovitex 2s |
| Abbvie INC. | $14.23 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $14.02 | 2019 | |
| Endogastric Solutions, INC | $8.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Leithead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.